1. Wan, Xueying, Guan, Shengdong, Hou, Yixuan, Qiu, Yuxiang, Liu, Manran. 2021. FOSL2 promotes VEGF-independent angiogenesis by transcriptionnally activating Wnt5a in breast cancer-associated fibroblasts. In Theranostics, 11, 4975-4991. doi:10.7150/thno.55074. https://pubmed.ncbi.nlm.nih.gov/33754039/
2. Sarode, Poonam, Zheng, Xiang, Giotopoulou, Georgia A, Seeger, Werner, Savai, Rajkumar. 2020. Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer. In Science advances, 6, eaaz6105. doi:10.1126/sciadv.aaz6105. https://pubmed.ncbi.nlm.nih.gov/32548260/
3. Zhang, Shujun, Li, Peilong, Li, Juan, Xu, Shuo, Wang, Chuanxin. 2023. Chromatin accessibility uncovers KRAS-driven FOSL2 promoting pancreatic ductal adenocarcinoma progression through up-regulation of CCL28. In British journal of cancer, 129, 426-443. doi:10.1038/s41416-023-02313-y. https://pubmed.ncbi.nlm.nih.gov/37380804/
4. Fisch, K M, Gamini, R, Alvarez-Garcia, O, Su, A I, Lotz, M K. 2018. Identification of transcription factors responsible for dysregulated networks in human osteoarthritis cartilage by global gene expression analysis. In Osteoarthritis and cartilage, 26, 1531-1538. doi:10.1016/j.joca.2018.07.012. https://pubmed.ncbi.nlm.nih.gov/30081074/
5. Liu, Naiquan, Li, Dongyang, Liu, Dajun, Liu, Ying, Lei, Jing. 2023. FOSL2 participates in renal fibrosis via SGK1-mediated epithelial-mesenchymal transition of proximal tubular epithelial cells. In Journal of translational internal medicine, 11, 294-308. doi:10.2478/jtim-2023-0105. https://pubmed.ncbi.nlm.nih.gov/37662889/